Oncolytics Biotech Inc T.ONC

A Catalyst New Event

[CarbonWarrior]

Okay, the case is rested.

This baby is a good one to bet on.
SP has bottomed adn is trading sideway or slightly upward. 

Next news event and we move to 5-6 range.
Accumulated, get in or regret it.

Next news event could be :

1. More impressive data
2. Partnership deal pancreatic
3. Partnership deal CART cell 
4. Partnership deal breast cancer
5.  Confirmation of existing data positive data
6. Friendly take over
7. Hostile take over

[westcoast1000]

After we had the stunning Goblet results and nothing really happened that lasted in terms of the share price, I do not think anything in terms of news releases will make much difference. 

[Hcallahan44]

Nothing is happening here ....possibly for another year or two....i am done getting my hopes up...this stock is my personal vietnam...

[CarbonWarrior]

I have trade this stock in and out for years now.  Buy low sell high. I think they are closer than ever now.  Best of luck for you.  Patient 013 is our lucky horse to bet on. That guy needs to live on and forever if possible. LOL.  Not sure why the market isn't reacting. All the analysts are quite bullish and positive here. Year end tax losess is almost over. 

[Hcallahan44]

Yes---the pattern is the same right before news sell....otherwise matt will hit the ATM and send the price down the drain again....i was planning to dump this time....but Matty is hitting the ATM earlier and earlier....rumored to have college tuitions to pay......he couldnt care less about shareholders....this is his candy machine

[CarbonWarrior]

Now that GOBLET is so awesome Almost forgot abou the other pancreatic trial Phase 2 NU 18I01  Pembrolizumab/ Keytruda (anti-PD1 mAb) Phase 2 NU 18I01:  https://www.streetwisereports.com/article/2021/08/18/biotech-offering-significant-return-potential-advances-lead-breast-cancer-trials.html This trial results could come out soon. Again this was totally discouted but new buzz can

[jimsenior]

@carbonW  - We should be very clear about ONCY trials as there are a number of them and one can get confused. The pancreatic trial you refer to with Keytruda NCT03723915 was Terminated. To my knowledge( and I am always happy to be corrected) the only ongoing trial with Keytruda is AMBUSH. It started recruiting 11/15/22 and is for Relapsed or Refractory Multiple Myeloma.  I think AMBUSH

[CarbonWarrior]

I think it still on. Leede Jones gable analysis: Final survival-PFStumor response data NU-18I01 Advanced pancreatic cancer (second-line) 30 Pembrolizumab/ Keytruda (anti-PD1 mAb) Northwestern Univ, US NCI H123 (May-21, ASCO) https://leedejonesgable.com/wp-content/uploads/ONC_2022_11_15.pdf (page 5) 

[jimsenior]

@carbonw. I have a sister who likes to wager, especially about politics. She usually bets to back up her political biases. That trial is Terminated. The GOBLET trial may be World Class.  Merck has seen fit to try Keytruda on MM. Some very sophisticated folks involved I mightt add. What is not to like. PS. My sister does not wager with me any more. Please do not put ire on my hole. Cheers

[Noteable]

Carbon .. jjimsenior is correct BU-18I01 was terminated even before it began likely because it was an investigator sponsored trial rather than like the a multi-center AOI trial and didn't involve the biomarkers used in the Goblet study.

[Buckhenry]

if you have been on this site for at least a week you have heard this 40 times. tell us something we don't know.

[CarbonWarrior]

BuckHenry I think you should sell and move on with your life. 

[Buckhenry]

well sell when in darn good and ready. and I did not say for u to like... I said it because it needed to be said. everyone posting the same ole crapolaon here if wishing and hoping. it will do whatever it does if and when it does. sugar plums dancing in ur head ain't going to help this stock.